shmt2 (Proteintech)
93
Structured Review
Proteintech
shmt2
Shmt2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+shmt2/ATIC+Antibody/pm41792114-416-70-71
Average 93 stars, based on 6 article reviews
Shmt2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+shmt2/ATIC+Antibody/pm41792114-416-70-71
Average 93 stars, based on 6 article reviews
shmt2 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Concentration Assay:Article Title: Proteomics and personalized patient-derived xenograft models identify treatment opportunities for a progressive malignancy within a clinically actionable timeframe and change care Article Snippet: .. Article Title: Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe Article Snippet: .. Incubation:Article Title: Proteomics and personalized patient-derived xenograft models identify treatment opportunities for a progressive malignancy within a clinically actionable timeframe and change care Article Snippet: .. Article Title: Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe Article Snippet: .. other:Article Title: De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma Article Snippet: Anti-PHGDH (14719-1-AP, RRID: AB_2283938), anti-phosphoserine phosphatase (PSPH; 14513-1-AP, RRID: AB_2171464), anti-SHMT1 (14149-1-AP, RRID: AB_2239222), anti-SHMT2 (11099-1-AP, RRID: AB_2188452), anti-actin (66009-1-Ig, RRID:AB_2687938), and Article Title: De Novo Serine Synthesis is a Metabolic Vulnerability that can be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma Article Snippet: Anti-PHGDH (14719-1-AP, RRID:AB_2283938), Anti-PSPH (14513-1-AP, RRID:AB_2171464), Anti-SHMT1 (14149-1-AP, RRID:AB_2239222), Anti-SHMT2 (11099-1- AP, RRID:AB_2188452), Anti-Actin (66009-1-Ig, RRID:AB_2687938), |